Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q4 Operating Loss Widens To SEK 12.4 Million

Feb 22 (Reuters) - Kancera AB  KANC.ST :
    * Q4 OPERATING  LOSS SEK 12.4 MILLION VERSUS LOSS SEK 11.9
MILLION
YEAR AGO
    * Q4 NET SALES SEK 0.3 MILLION VERSUS SEK 0 MILLION YEAR AGO

Source text for Eikon:  ID:nWkr51kb17 
Further company coverage:  KANC.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Novakand Pharma AB

See all news